NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 101 filers reported holding NATERA INC in Q2 2016. The put-call ratio across all filers is 5.75 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,292,000 | -23.6% | 62,700 | -48.3% | 0.06% | -48.7% |
| Q4 2018 | $1,691,000 | +33.6% | 121,200 | +129.1% | 0.12% | +62.5% |
| Q3 2018 | $1,266,000 | +27.2% | 52,899 | 0.0% | 0.07% | +24.1% |
| Q2 2018 | $995,000 | +33.7% | 52,899 | -34.1% | 0.06% | +20.8% |
| Q1 2018 | $744,000 | -0.7% | 80,300 | -3.7% | 0.05% | +20.0% |
| Q4 2017 | $749,000 | -37.0% | 83,395 | -9.6% | 0.04% | -37.5% |
| Q3 2017 | $1,189,000 | -48.8% | 92,300 | -56.9% | 0.06% | -55.2% |
| Q2 2017 | $2,324,000 | +74.1% | 214,000 | +42.1% | 0.14% | +70.2% |
| Q1 2017 | $1,335,000 | -1.2% | 150,600 | +34.5% | 0.08% | -33.3% |
| Q2 2016 | $1,351,000 | – | 112,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
| Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
| Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
| Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
| Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
| Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
| BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
| PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
| RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |